Medistim ASA: Business Overview, Financials & Competitive Analysis
Medistim ASA scores 7/10 on the AskCyborg Cyborg Score (Strong). Specialized medtech leader with proven TTFM technology and international growth trajectory, trading at public markets with stable fundamentals and emerging market tailwinds. Medistim holds a defensible market-leading position in a specialized but growing surgical technology segment with global expansion momentum. Recent geographic expansion and Export Award recognition demonstrate execution capability.
What is Medistim ASA's industry? Medistim ASA (medistim.com) operates in Medical Device Manufacturing - Surgical Imaging & Hemodynamic Monitoring. AskCyborg classifies Medistim ASA under Medical Device Manufacturing - Surgical Imaging & Hemodynamic Monitoring in its company registry.
Medistim ASA is a public company listed on Oslo Stock Exchange – a market leader within intra-operative transit time flow measurement (TTFM) and ultrasound imaging, providing the MiraQ™ system to the global market. Th...
Cyborg Score thesis
Specialized medtech leader with proven TTFM technology and international growth trajectory, trading at public markets with stable...
Read the full analyst-debate transcript →Get the Latest Medistim ASA Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeMedistim ASA Overview
Pro stress-test →Medistim ASA is a public company listed on Oslo Stock Exchange – a market leader within intra-operative transit time flow measurement (TTFM) and ultrasound imaging, providing the MiraQ™ system to the global market. These systems enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery.
Strategic Profile
Pro stress-test →In 2023, Medistim significantly grew its direct sales footprint by adding China, Canada, and Sweden to its list of direct countries. Medistim is the market leader in intraoperative ultrasonic guidance and quality assessment focused on improving surgical outcomes. The company combines proprietary TTFM technology with ultrasound imaging in a unified platform designed for intraoperative use.
Competitive Landscape
Pro stress-test →Competitors include Cook Medical Inc., Transonic Systems Inc., Deltex Medical Group PLC, Atys Medical, Getinge Group, Perimed AB, and others. Medistim differentiates through integrated TTFM + ultrasound imaging platform targeting cardiac, vascular, and transplant surgical markets where intraoperative blood flow verification is critical.
Industry Context
Medistim ASA operates in Medical Device Manufacturing - Surgical Imaging & Hemodynamic Monitoring.
Key facts
Founded: 1984 · Headquarters: Oslo, Norway · Employees: 119 · Revenue: $35M